There’s a lot of buzz these days around the role that AI will play in pharmaceutical R&D – from target identification to therapeutic design and optimization, from patient stratification to clinical trial design and site selection, and beyond.
So what’s real, and what’s just hype?
Join JLABS for an engaging panel discussion – featuring representatives from the pharmaceutical industry, the startup world and the investor community – focused on how AI is driving the discovery, development and delivery of innovative medicines today, and what the future holds in this rapidly-evolving space. Followed by an exciting celebratory reception to commemorate JLABS at NYC Six-Year Anniversary!
RSVP here.